---
schema_version: "secwatch.filing_event.v1"
accession: "0001372514-24-000013"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:12:08.414108+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Kiora Pharmaceuticals furnishes updated investor presentation; no material new information disclosed

## Summary
- Filed an updated corporate overview presentation dated H1 2024 under Regulation FD.
- Presentation is available for use in investor meetings and web postings.
- No financial results, clinical data, or operational changes were announced in the filing.
- Ticker KPRX; the filing does not contain any guidance or material events.

## SEC filing metadata
- accession: 0001372514-24-000013
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000013/0001372514-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000137251424000013/kprx-20240212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001372514-24-000013
- JSON: https://secwatch.observer/filing/0001372514-24-000013.json
- Plain text: https://secwatch.observer/filing/0001372514-24-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.